Literature DB >> 6129524

Ivermectin in onchocerciasis.

M A Aziz, S Diallo, M Lariviere, I M Diop, I M Porta, P Gaxotte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6129524     DOI： 10.1016/s0140-6736(82)91350-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

Authors:  H S Newland; A T White; B M Greene; S A D'Anna; E Keyvan-Larijani; M A Aziz; P N Williams; H R Taylor
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

Review 2.  Philosophy of new drug discovery.

Authors:  S Omura
Journal:  Microbiol Rev       Date:  1986-09

Review 3.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

4.  Effect of ivermectin against subperiodic Brugia malayi infection in the leaf monkey, Presbytis cristata.

Authors:  J W Mak; P L Lam; A N Rain; K Suresh
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

Review 5.  Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance.

Authors:  Roger K Prichard; Timothy G Geary
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-06-15       Impact factor: 4.077

6.  Extracts of Euphorbia hirta Linn. (Euphorbiaceae) and Rauvolfia vomitoria Afzel (Apocynaceae) demonstrate activities against Onchocerca volvulus microfilariae in vitro.

Authors:  Simon K Attah; Patrick F Ayeh-Kumi; Archibald A Sittie; Isaac V Oppong; Alexander K Nyarko
Journal:  BMC Complement Altern Med       Date:  2013-03-18       Impact factor: 3.659
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.